At Nuvaira, our mission is to transform the standard of care and significantly improve patient outcomes for those living with obstructive lung diseases. Our investigational device, the dNerva® Lung Denervation System, is a catheter-based system used to treat overactive airways that may help to reduce the frequency and severity of Chronic Obstructive Lung Disease (COPD) exacerbations for those patients already on optimal drug therapy. Stop by our booth to check out our technology and learn more about our current AIRFLOW-3 Clinical Trial.